AGBL2 and rheumatoid arthritis: The first study described significantly lower levels of 22:6; 20:5 + 22:6 and total ω-3 FA% in erythrocytes of patients who tested positive for anti-CCP2 autoantibodies (an RA-specific autoantibody) [135].